U.S. Diagnostic Imaging Services Market to Grow at a CAGR of 7.0% over 2025 to 2032; Technological Advancements in MRI and Expanded Insurance Coverage to Support Market Growth

The U.S. diagnostic imaging services market size was valued at USD 140.21 billion in 2024. The market is projected to grow from USD 149.54 billion in 2025 to USD 239.74 billion by 2032, exhibiting a CAGR of 7.0% during the forecast period. Fortune Business Insights™ presents this information in its report titled “U.S. Diagnostic Imaging Services Market Size, Share & Industry Analysis, By Procedure (CT, MRI, X-Ray, Ultrasound, and Others), By Application (Cardiology, Neurology, Oncology, Orthopedics, Gynecology, and Others), By Payor (Public Health Insurance and Private Health Insurance/Out of Pocket), and By Setting (Hospital In-patient, Hospital Outpatient (HOPD), Freestanding Imaging Centers, and Others), and Country Forecast, 2025-2032 ”.

Diagnostic imaging services, including MRI and other non-invasive modalities, are essential for efficient disease detection. Diagnostic imaging, including MRI and other non-invasive modalities, is essential for efficient disease detection. Advancements in MRI technology, increased clinical use, wider insurance support, and innovative services by leading companies are fueling sustained market growth.

DeepHealth, Inc. Launched AI-driven Solutions to Enhance Diagnostic Accuracy and Operational Efficiency

At RSNA 2024, DeepHealth, Inc. launched AI-driven solutions to advance imaging diagnostics and large-scale screening. Its SmartTechnology integrated AI and informatics for efficient, patient-focused workflows. Powered by DeepHealth OS, the platform enhances clinical performance and operational efficiency. Collaborations with industry leaders support continuous innovation in imaging care. 

Increasing Prevalence of Chronic Diseases and Related Complications to Drive Market Growth

Chronic disease incidence in the U.S. is rising sharply, significantly increasing the demand for diagnostic imaging services. With the aging population more prone to cancers and heart diseases, imaging tools such as ultrasound and MRI are essential for early diagnosis. In 2024, over 25,400 malignant brain and spinal tumors were witnessed, as per NFCR study. Additionally, in March 2023, GE Healthcare reported that 20 million Americans report chest pain annually, driving Cardiac imaging needs. These trends underscore robust U.S. diagnostic imaging services market growth.

Moreover, the market has witnessed swift transformation, fueled by innovative business models, strategic alliances, and diagnostic imaging with an aim to enhance diagnostic accuracy and treatment planning. The growing adoption of cryogen-free MRI systems along with IoT are some of the other reasons that are shaping the industry's expansion.   

However, concerns over potential side effects of medical imaging procedures are restraining market expansion.

Industry Participants Focus on Partnerships to Expand their Footprints

In 2024, RadNet, Inc., Akumin, Inc., and Rayus Radiology led the U.S. diagnostic imaging services market.  RadNet, Inc. leads with 398 outpatient centers and 10 million annual procedures, strengthened by its acquisition of DeepHealth, Inc. to expand its footprint. Akumin ranks second, driven by its innovative platform and flexible solutions for hospitals and physician groups. Other notable players include US Radiology Specialists, Radiology Partners, SimonMed, and LucidHealth, Inc. also captured significant market shares owing to their diverse diagnostic imaging service offerings.     

List of Key Players Mentioned in the Report:

• RadNet, Inc. (U.S.)
• Akumin, Inc. (U.S.)
• Rayus Radiology (U.S.)
• MedQuest Associates (U.S.)
• LucidHealth, Inc. (U.S.)
• US Radiology Specialists (U.S.)
• Radiology Partners (U.S.)
• Envision Radiology (U.S.)
• Capitol Imaging Services (U.S.)

Key Industry Development:

• November 2024: In a strategic collaboration, RadNet Inc. and GE HealthCare launched SmartMammo, an AI-powered breast cancer screening tool for the Senographe Pristina system, aiming to advance imaging precision and streamline radiology workflows.

Further Report Findings

• As per application, the market is fragmented into cardiology, neurology, oncology, orthopedics, gynecology, and others. In 2024, the neurology segment captured the highest market share, fueled by the rising prevalence of neurological disorders and strokes. Imaging tools are vital for diagnosing conditions such as Parkinson's, which affects around 1 million Americans as of 2025, a number expected to rise to 1.2 million by 2030, according to Parkinson's Foundation.
• Based on procedure, the market is segmented into CT, MRI, X-ray, ultrasound, and others. In 2024, the CT segment held the largest U.S. diagnostic imaging services market share, fueled by increased chronic disease cases such as cancer and heart conditions. The American Cancer Society projected 2.0 million diagnoses in 2024, boosting CT usage. OECD reported 84.5 million CT scans in 2021, marking a 15.8% Y-O-Y rise.
• In terms of payor, the market is bifurcated into public health insurance and private health insurance/out-of-pocket. In 2024, the private health insurance/out-of-pocket segment held the apex position in the U.S. market, driven by the growing working population opting for private coverage.
• By setting, the market is divided into hospital in-patient, Hospital Outpatient (HOPD), freestanding imaging centers, and others. The hospital in-patient segment held the key share of the market in 2024. This growth of the segment is fueled by increasing patient preference for hospitals offering one-stop diagnosis and treatment services.

Table of Segmentation